Preclinical Implications for Existing, and New Circulatory Assist Devices

The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…

Center for Medtech Excellence Shares 2023, 2024 Cohort Dates

Medtech startups or established businesses looking to scale are encouraged to apply for one of the upcoming 16-week accelerator cohorts at the Center for MedTech Excellence. Launched in September 2022, the Center for Medtech Excellence catalyzes the development and commercialization of breakthrough biotechnology, medical devices, life science and therapeutic innovations. Primary areas of focus include…

Moving Beyond Improvisation. Solving a High Volume, High Value Unmet Clinical Need to Advance Patient Care

A “Catheter Gripping Tool” solving an unmet need as GCMI’s grows its roster of collaborative medtech innovations with the Children’s Mercy Kansas City Center for Pediatric Innovation.   Human beings are generally good at improvisation. Assembly calls for a 10mm socket? Try this handy crescent wrench right here and maybe it will do. What happened…

Onsite State-of-the-Art CT Scanner Adds Capability, Efficiency, Time and Cost-Savings for GCMI Preclinical Customers

Image credit: Clinical Imaging Systems GCMI, the U.S. proving ground for medtech innovation, has recently acquired a GE LightSpeed VCT 64 Slice CT Scanner with cardiac gating capabilities. “The ability for these machines to generate 3D images of anatomic structures and organs in a pre-op, post-op or intra-operative scenario, including cardiac and vascular imaging, has…

GCMI CEO Sherry Farrugia Named 2023 Recipient of the Center for Global Health Innovation’s Highest Honor, the Industry Growth Award.

The Center for Global Health Innovation (CGHI) recently announced the winners of its 2023 Golden Helix Awards. Congratulations to GCMI’s CEO, Sherry Farrugia, recipient of the 2023 Industry Growth Awards for her impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by CGHI.  …

Aligned Career Opportunity: Project Manager to Advance Research and Education in Neuroscience.

Our colleague Chris Rozell, Professor and Julian T. Hightower Chair,Technical Interest Groups: Bioengineering, Digital Signal Processing at Georgia Tech asked us to share the following career opportunity advancing research and education in neuroscience. We hope this initiative and position will have the opportunity to work closely with GCMI in the future. From Chris: Georgia Tech…

Come work with our industry leading medtech innovation design and development team – Seeking a senior research engineer to join the GCMI team

GCMI, a non-profit affiliate of the Georgia Institute of Technology, is actively recruiting for a research engineer to lead multiple new medtech product development projects.   The medical device design services and product development team at GCMI facilitates medical product development through all phases – from initial concept generation through transfer to production manufacturing. We…

Beware the Unfamiliar Approach: Preclinical Implications for Novel Cell & Gene Therapies

Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells.    Because…

Who brings what to the table? Artivion’s Deepal Stevenson, M.S. shares her insights on the client / CRO relationship for effective, efficient preclinical studies and reports.

Life science companies of all shapes and sizes rely on preclinical contract research organizations (CROs) to generate the data and reports required to bring their innovations to market.   To do this effectively, and in a capital efficient manner, each entity needs to understand what they need from the other, when they need it, why…

Q&A with an Industry Leader – What’s One Area Especially Ripe for Acceleration in Preclinical Work? Hint: It’s Not the OR.

As we shared recently, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…